AAM All Access Podcast - AAM CEO Dan Leonard convenes industry and policy experts to explore why the Inflation Reduction Act (f/k/a Build Back Better) reduces generic and biosimilar competition.
AAM’s “Voices of Access” report features patients across the country speaking about the importance of generic and biosimilar medicines in their lives. This annual publication tells the impact that accessible medicines have on everyday Americans – on their health journeys, their economic well-being and their daily lives.
Click here for mobile-friendly version.
Meet the AAM Patients
Read their story on the AAM blog:
Listen to Their Stories
Video
Aug 15, 2021 | Evan Chernicky
Akaimi's Story — Savings from Biosimilar Medicines
Video
Sep 12, 2018 | Erica Klinger
Ariel's Story – Savings from Generic Medicines
Video
May 22, 2021 | Erica Klinger
Doug's Story – Savings from Generic Medicines
Video
Feb 18, 2022 | Ericka Nguyen
Eileen's Story – Savings from Biosimilar Medicines
Video
Feb 18, 2022 | Ericka Nguyen
Greg's Story – Savings from Biosimilar Medicines
Video
Dec 17, 2020 | Erica Klinger
Helen's Story — Savings from Biosimilar Medicines
Video
Oct 8, 2020 | Erica Klinger
Jeni's Story — Savings from Biosimilar Medicines
Video
Jan 17, 2019 | Erica Klinger
Jonnie's Story – Savings from Generic Medicines
Video
Feb 18, 2022 | Ericka Nguyen
KC's Story – Savings from Generic Medicines
Video
Dec 14, 2018 | Erica Klinger
Keon's Story – Savings from Generic Medicines
Video
May 22, 2021 | Erica Klinger
McKenzie's Story – Savings from Generic Medicines
Video
May 22, 2021 | Erica Klinger
Michelle's Story — Savings from Generic Medicines